CUSIP: 75915K200
Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
8,615,363
-
Share change
-
+1,462,499
-
Total reported value
-
$3,970,077
-
Price per share
-
$0.46
-
Number of holders
-
22
-
Value change
-
+$671,672
-
Number of buys
-
8
-
Number of sells
-
7
Quarterly Holders Quick Answers
What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2020
-
Previous quarter:
Q4 2019
Recent filing periods for CUSIP 75915K200:
Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) as of Q1 2020
As of 31 Mar 2020,
REGULUS THERAPEUTICS INC - COM NEW (RGLS) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,615,363 shares.
The largest 10 holders included
NEA Management Company, LLC, EcoR1 Capital, LLC, Sarissa Capital Management LP, BVF INC/IL, RENAISSANCE TECHNOLOGIES LLC, CVI Holdings, LLC, Rockefeller Capital Management L.P., SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Inc..
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.